Ana Batlle‐López

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of <i>TP53/ATM FISH</i> deletions

Anna Puiggros, Rosa Collado, Marı́a José Calasanz et al. · Oncotarget · 2017 · 47 citations · Full text

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Ana Batlle‐López, Sonia González de Villambrosía, Francisco Mazorra et al. · Oncotarget · 2016 · 33 citations · Full text

Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells

María G. Cortiguera, Lorena García-Gaipo, Simon D. Wagner et al. · Scientific Reports · 2019 · 31 citations · Full text

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

Juan‐Manuel Sancho, Rubén Fernández-Álvarez, Francisco Gual‐Capllonch et al. · Cancer Medicine · 2021 · 28 citations · Full text

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

Juan M. Caraballo, Juan Carlos Acosta, M. Alicia Cortés et al. · Oncotarget · 2014 · 26 citations · Full text